| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000019872 |
| Receipt No. | R000022812 |
| Scientific Title | Relationship between Mitochondrial DNA Damage and Atherosclerosis |
| Date of disclosure of the study information | 2015/11/20 |
| Last modified on | 2019/05/24 (Ver. 6) |
| Basic information | ||
| Public title | Relationship between Mitochondrial DNA Damage and Atherosclerosis | |
| Acronym | Mitochondrial DNA Damage and Atherosclerosis | |
| Scientific Title | Relationship between Mitochondrial DNA Damage and Atherosclerosis | |
| Scientific Title:Acronym | Mitochondrial DNA Damage and Atherosclerosis | |
| Region |
|
|
| Condition | ||
| Condition | Healthy volunteer, patietns with hypertension, dyslipidemia, diabetes, chronic kidney disease, peripheral artery disease, coronary heart disease, cerebrovascular disease, or heart failure, and current smoker. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the association of mtDNA damage level with conventional cardiovascular risk factors such as hypertension, diabetes, and dyslipidemia to determine whether mtDNA damage level is a useful marker of atherosclerosis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | (1)The association between mtDNA damage level and conventional cardiovascular risk factors.
(2) The association between mtDNA damage level and endothelial function. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy volunteer, patients with hypertension, dyslipidemia, diabetes, chronic kidney disease, peripheral artery disease, coronary artery diesase, cerebrovascular disease or heart failure, and current smoker. | |||
| Key exclusion criteria | Patients who are considered not eligible for the study by the attending doctor. | |||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Research Institute for Radiation Biology and Medicine, Hiroshima University | ||||||
| Division name | Department of Cardiovascular Regeneration and Medicine | ||||||
| Zip code | 734-8551 | ||||||
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima | ||||||
| TEL | 082-257-5831 | ||||||
| yhigashi@hiroshima-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Hiroshima University | ||||||
| Division name | Department of Cardiovascular Medicine, Graduate School of Biomedical & Health Sciences | ||||||
| Zip code | 734-8551 | ||||||
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima | ||||||
| TEL | 082-257-5540 | ||||||
| Homepage URL | |||||||
| 55maruchin@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB of Hiroshima University |
| Address | 1-2-3, Kasumi, Minami-ku, Hiroshima |
| Tel | 082-257-5907 |
| kasumi-kenkyu@office.hiroshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | not released |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | not released | ||||||
| Number of participants that the trial has enrolled | 175 | ||||||
| Results | We enrolled 175 subjects. We assessed the associations of mtDNA with traditional risk factors and flow-mediated vasodilation. However, there was no significant associations between them, indicating that mtDNA may not be useful as a marker of atherosclerosis. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Patients with coronary risk factors |
||||||
| Participant flow | We enrolled 175 patients from outpatient clinic. |
||||||
| Adverse events | none |
||||||
| Outcome measures | We assessed the associations of mtDNA with traditional risk factors and flow-mediated vasodilation. However, there was no significant associations between them. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | (1)Cross-sectional study
(2)We enroll subjects who visit our hospital from December 2015 to March 2018 and meet the inclusion criteria. (3)We measure mtDNA damage level, endothelial function, blood pressure, lipid profile, and glucose level. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022812 |